Congress·In Committee·H.R. 2767
Rep. Fitzpatrick Introduces BRAIN Act to Boost Funding for Brain Cancer Research and Treatment
BRAIN Act
Legislative Progress
House
Senate
President
Law
Key Points
- The bill creates a Glioblastoma Therapeutics Network with $50 million per year for five years to fund collaborative research that moves potential brain cancer treatments from lab studies into early human clinical trials.
From policy text
“There is authorized to be appropriated $50,000,000 for each of fiscal years 2026 through 2030, to remain available until expended, to the Director of the Institute to carry out this section.”
View in full text - A new public database of brain tumor tissue samples funded by NIH would be created, requiring researchers to report their collections within 180 days (existing) or 60 days (new). Those who repeatedly fail to report could lose federal funding.
From policy text
“The Secretary, acting through the Director of NIH, may establish and maintain a searchable website, or multiple websites, which may include websites existing on the day before the date of enactment of this section, for the purpose of making accessible to the public--”
View in full text - A $10 million national public awareness campaign would educate patients, caregivers, and doctors about cancer clinical trials and biomarker testing, with special outreach to high-risk populations, rural communities, and underserved groups.
From policy text
“The Secretary shall carry out a national campaign to increase the awareness and knowledge of health care providers and individuals, including patients and caregivers, with respect to the importance of clinical trials in the treatment of cancer.”
View in full text - The bill authorizes $10 million per year for a CAR-T cell immunotherapy team science award, funding multi-institutional research on promising cellular immunotherapy treatments for adult and pediatric brain tumors.
From policy text
“the Director of the Institute shall make awards, on a competitive basis, through a U series funding mechanism, to support the development of a multi-institutional team science approach to using brain tumor related cancer cellular immunotherapy, including CAR-T treatment, for adult and pediatric brain tumors.”
View in full text - Pilot programs receiving $5 million per year would study models for long-term monitoring and care of brain tumor survivors, including mental health support, care coordination, and tools that may use artificial intelligence.
From policy text
“The Director of NIH may, as appropriate, make awards to eligible entities to establish pilot programs to develop, study, or evaluate approaches, including primary and specialty care, for monitoring and caring for adult and pediatric brain tumor survivors throughout their lifespan”
View in full text - The FDA must issue guidance within one year to reduce the exclusion of brain tumor patients from clinical trials designed for other types of cancer, potentially opening up more treatment options for these patients.
From policy text
“the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall issue guidance to help identify ways to minimize the potential for the exclusion of brain tumor patients and patients with rare and recalcitrant cancers from clinical trials evaluating treatments for other indications.”
View in full text
Healthcare
Impact Analysis
Personal Impact
Who is affectedScoreImpactCertaintyScopeDurationSentiment
Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)
Milestones
2 milestones2 actions
Apr 9, 2025House
Referred to the House Committee on Energy and Commerce.
Apr 9, 2025
Introduced in House
What Happens Next
Projected impacts based on AI analysis
Within 1 year of enactment
FDA must issue guidance on reducing brain tumor patient exclusion from clinical trials
Brain tumor patients and those with rare cancers may gain access to more clinical trials testing treatments originally designed for other conditions
Within 180 days of enactment
Holders of NIH-funded brain tumor biospecimen collections must report to the public database
Researchers will be able to search a centralized website to find brain tumor tissue samples for their studies, speeding up the pace of discovery
Related Bills
1 billSource Information
Document Type
Congressional Bill
Official Title
BRAIN Act
Bill NumberHR 2767
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the House Committee on Energy and Commerce.
Sponsor
Cosponsors
(47)D: 39R: 8
Data Sources
Analysis generated by AI. Always verify with official sources.